These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
495 related articles for article (PubMed ID: 27641813)
1. Δ Shang VC; Kendall DA; Roberts RE Biochem Pharmacol; 2016 Nov; 120():63-71. PubMed ID: 27641813 [TBL] [Abstract][Full Text] [Related]
2. The endogenous cannabinoid anandamide increases human airway epithelial cell permeability through an arachidonic acid metabolite. Shang VC; O'Sullivan SE; Kendall DA; Roberts RE Pharmacol Res; 2016 Mar; 105():152-63. PubMed ID: 26808080 [TBL] [Abstract][Full Text] [Related]
3. Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37. Tatsuta M; Kan-O K; Ishii Y; Yamamoto N; Ogawa T; Fukuyama S; Ogawa A; Fujita A; Nakanishi Y; Matsumoto K Respir Res; 2019 Nov; 20(1):251. PubMed ID: 31706310 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability. Harvey BS; Nicotra LL; Vu M; Smid SD Cytokine; 2013 Aug; 63(2):209-17. PubMed ID: 23706402 [TBL] [Abstract][Full Text] [Related]
5. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal. Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor CB2 is involved in tetrahydrocannabinol-induced anti-inflammation against lipopolysaccharide in MG-63 cells. Yang L; Li FF; Han YC; Jia B; Ding Y Mediators Inflamm; 2015; 2015():362126. PubMed ID: 25653478 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro. Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991 [TBL] [Abstract][Full Text] [Related]
8. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier. Moran GW; O'Neill C; McLaughlin JT Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889 [TBL] [Abstract][Full Text] [Related]
9. Cigarette smoke-induced disruption of bronchial epithelial tight junctions is prevented by transforming growth factor-β. Schamberger AC; Mise N; Jia J; Genoyer E; Yildirim AÖ; Meiners S; Eickelberg O Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1040-52. PubMed ID: 24358952 [TBL] [Abstract][Full Text] [Related]
11. Effects of hyperoxia on the permeability of 16HBE14o- cell monolayers--the protective role of antioxidant vitamins E and C. Al-Shmgani HS; Moate RM; Macnaughton PD; Sneyd JR; Moody AJ FEBS J; 2013 Sep; 280(18):4512-21. PubMed ID: 23809212 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol. DeLong GT; Wolf CE; Poklis A; Lichtman AH Drug Alcohol Depend; 2010 Nov; 112(1-2):126-33. PubMed ID: 20619971 [TBL] [Abstract][Full Text] [Related]
13. The molecular mechanism and effect of cannabinoid-2 receptor agonist on the blood-spinal cord barrier permeability induced by ischemia-reperfusion injury. Yang MC; Zhang HZ; Wang Z; You FL; Wang YF Brain Res; 2016 Apr; 1636():81-92. PubMed ID: 26835555 [TBL] [Abstract][Full Text] [Related]
14. Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists. Henriquez JE; Crawford RB; Kaminski NE Toxicol Appl Pharmacol; 2019 Apr; 369():82-89. PubMed ID: 30807757 [TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour. Grey J; Terry P; Higgs S Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability. Alhamoruni A; Lee AC; Wright KL; Larvin M; O'Sullivan SE J Pharmacol Exp Ther; 2010 Oct; 335(1):92-102. PubMed ID: 20592049 [TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ⁹-THC. Coskun ZM; Bolkent S Cell Biochem Funct; 2014 Oct; 32(7):612-9. PubMed ID: 25187240 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2. Xie J; Xiao D; Xu Y; Zhao J; Jiang L; Hu X; Zhang Y; Yu L Oncotarget; 2016 Feb; 7(6):6436-47. PubMed ID: 26824325 [TBL] [Abstract][Full Text] [Related]
20. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats. Calik MW; Carley DW Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]